Recombinant Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3)

CDHF11; EGFL1; FMI1; HFMI1; MEGF2; RESDA1; Cadherin family member 11; Epidermal growth factor-like protein 1; Multiple epidermal growth factor-like domains protein 2

  • Product No.RPG434Hu01
  • Organism SpeciesHomo sapiens (Human) Same name, Different species.
  • SourceProkaryotic expression
  • HostE.coli
  • Endotoxin Level<1.0EU per 1µg (determined by the LAL method)
  • Subcellular LocationMembrane
  • Predicted Molecular Mass31.3kDa
  • Accurate Molecular Mass31kDa(Analysis of differences refer to the manual)
  • Residues & TagsSer1181~Cys1421 with N-terminal His Tag
  • Buffer FormulationPBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder
  • Purity> 97%
  • Isoelectric Point4.9
  • Applications Positive Control; Immunogen; SDS-PAGE; WB.
    If bio-activity of the protein is needed, please check active protein.
  • DownloadInstruction Manual
  • UOM 10µg50µg 200µg 1mg 5mg
  • FOB US$ 168  US$ 420  US$ 840  US$ 2520  US$ 6300 
    For more details, please contact local distributors!

SEQUENCE

USAGE

Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

STORAGE

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

STABILITY

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

GIVEAWAYS

INCREMENT SERVICES

Catalog No. Related products for research use of Homo sapiens (Human) Organism species Applications (RESEARCH USE ONLY!)
RPG434Hu01 Recombinant Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) Positive Control; Immunogen; SDS-PAGE; WB.
PAG434Hu01 Polyclonal Antibody to Cadherin EGF LAG Seven Pass G-Type Receptor 3 (CELSR3) WB; IHC; ICC; IP.